Orbcel-C clinical trials

Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

This study is testing a new cell treatment, Orbcel-C, for liver conditions called Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH). We want to find the safest dose and see if it helps reduce inflammation.